Universitat Autònoma de Barcelona-ko ikertzaileekin lankidetzan egindako argitalpenak (6)

2021

  1. Long runs of homozygosity are associated with Alzheimer’s disease

    Translational Psychiatry, Vol. 11, Núm. 1

2020

  1. Validation of a 52-mtSNP minisequencing panel for haplogroup classification of forensic DNA samples

    International Journal of Legal Medicine, Vol. 134, Núm. 3, pp. 929-936

2019

  1. Genome-wide association analysis of dementia and its clinical endophenotypes reveal novel loci associated with Alzheimer's disease and three causality networks: The GR@ACE project

    Alzheimer's and Dementia, Vol. 15, Núm. 10, pp. 1333-1347

2016

  1. CYP2C9 variants as a risk modifier of NSAID-related gastrointestinal bleeding: A case-control study

    Pharmacogenetics and Genomics, Vol. 26, Núm. 2, pp. 66-73

2015

  1. MAPT H1 haplotype is associated with late-onset Alzheimer's disease risk in APOE ε 4 noncarriers: Results from the dementia genetics Spanish consortium

    Journal of Alzheimer's Disease, Vol. 49, Núm. 2, pp. 343-352

2014

  1. Assessing the role of the TREM2 p.R47H variant as a risk factor for Alzheimer's disease and frontotemporal dementia

    Neurobiology of Aging, Vol. 35, Núm. 2, pp. 444.e1-444.e4